Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed)
This grant supports early-stage research for developing new drugs to treat specific fungal infections caused by Candida auris, Aspergillus fumigatus, Coccidioides, and Mucorales. It uses a two-phase award system where progression to the second phase depends on achieving certain goals in the first phase.
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of Health
-
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
National Institutes of Health
-
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
National Institutes of Health
-
DoW Peer Reviewed Medical, Clinical Trial Award
Dept. of the Army -- USAMRAA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers